13
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Idarubicin in Combination with Cytarabine and VP-16 in the Treatment of post Myelodysplastic Syndrome Acute Myeloblastic Leukemia (MDS-AML)

, , , , &
Pages 473-477 | Received 24 Dec 1994, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

R. Latagliata, M. Breccia, A. Pulsoni, M. A. Aloe Spiriti, G. M. D'elia, A. Spadea, E. Montefusco, G. Luzi, P. Betró & M. C. Petti. (2000) Acute Myeloblastic Leukemia Secondary to Myelodysplasia (MDS-AML): A Comparison of Remission Induction with Three Drugs Versus Standard Two-Drugs Induction. Leukemia & Lymphoma 36:5-6, pages 539-541.
Read now

Articles from other publishers (3)

Andrew KuykendallNicolas DuployezNicolas BoisselJeffrey E. LancetJohn S. Welch. (2018) Acute Myeloid Leukemia: The Good, the Bad, and the Ugly. American Society of Clinical Oncology Educational Book:38, pages 555-573.
Crossref
R. G. Geissler, D. Hoelzer, W. K. Hofmann, G. Heil, O. G. Ottmann, J. T. Fischer, W. Langer, F. Herrmann, A. Knuth, K. Höffken, K. Kolbe, H. J. Schmoll, M. Karthaus, H. Drolshagen & A. Ganser. 1998. Acute Leukemias VII. Acute Leukemias VII 963 966 .
Kaoru Tohyama, Hiroshi Tsutani, Yuji Wano, Hiromichi Iwasaki, Toshihiro Fukushima, Yoshimasa Urasaki, Yasukazu Kawai, Toru Nakamura, Yataro YoshidaTakanori Ueda. (1997) Anti-Leukemia Chemotherapy of High-Risk Myelodysplastic Syndromes. The Oncologist 2:3, pages 160-163.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.